Vaccines as an agent for immunization against HPV
Considered a highly prevalent infection throughout the world, the human papillomavirus (HPV) is a DNA virus that infects the genital mucosa and has high carcinogenic potential, being related to an increased risk of lower genital tract lesions, such as cervical cancer. This cancer is responsible for...
Gespeichert in:
| Veröffentlicht in: | Ciência & saude coletiva 2014-09, Vol.19 (9), p.3799 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 9 |
| container_start_page | 3799 |
| container_title | Ciência & saude coletiva |
| container_volume | 19 |
| creator | Zardo, Geisa Picksius Farah, Flávia Peixoto Mendes, Fernanda Gabriela Franco, Camila Ament Giuliani Dos Santos Molina, Giseli Vieira Machado Melo, Gislaine Nochetti de Kusma, Solena Ziemer |
| description | Considered a highly prevalent infection throughout the world, the human papillomavirus (HPV) is a DNA virus that infects the genital mucosa and has high carcinogenic potential, being related to an increased risk of lower genital tract lesions, such as cervical cancer. This cancer is responsible for the deaths of about 231,000 women per year worldwide, which means that HPV is a major problem for public health. Knowing that the most effective and cost-effective way to control an infectious disease is the development of vaccines, two prophylactic vaccines have been developed and approved in Brazil, one of which is bivalent and the other is tetravalent. This review of the literature seeks to present the characteristics of the HPV virus, types of vaccines available on the market, their indications and contraindications, their adverse effects, their effectiveness, their geometric mean titer (GMT) and their cost-effectiveness. |
| doi_str_mv | 10.1590/1413-81232014199.01532013 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_25184585</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>25184585</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-250086a7bb2f1d5a610c488263acacddd140354ee613a0769a5bb4d4b86a0af43</originalsourceid><addsrcrecordid>eNo1jt1Kw0AUhBdBbK2-gqwPsPWc_cvmUopaoaAX2tty9ieyYtKQTS_06U2xwsB8DMwwjN0iLNHUcIcalXAolYQJ63oJaI6sztgcbeWENhZn7LKUTwBZKS0v2EwadNo4M2e4pRBylwqnSR2nj9SNvNkPPLftocs_NOb9MabclZGvX7dX7Lyhr5KuT75g748Pb6u12Lw8Pa_uN6JHcKOQBsBZqryXDUZDFiFo56RVFCjEGFGDMjoli4qgsjUZ73XUfioBNVot2M3fbn_wbYq7fsgtDd-7_-_qF65DRMU</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Vaccines as an agent for immunization against HPV</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Zardo, Geisa Picksius ; Farah, Flávia Peixoto ; Mendes, Fernanda Gabriela ; Franco, Camila Ament Giuliani Dos Santos ; Molina, Giseli Vieira Machado ; Melo, Gislaine Nochetti de ; Kusma, Solena Ziemer</creator><creatorcontrib>Zardo, Geisa Picksius ; Farah, Flávia Peixoto ; Mendes, Fernanda Gabriela ; Franco, Camila Ament Giuliani Dos Santos ; Molina, Giseli Vieira Machado ; Melo, Gislaine Nochetti de ; Kusma, Solena Ziemer</creatorcontrib><description>Considered a highly prevalent infection throughout the world, the human papillomavirus (HPV) is a DNA virus that infects the genital mucosa and has high carcinogenic potential, being related to an increased risk of lower genital tract lesions, such as cervical cancer. This cancer is responsible for the deaths of about 231,000 women per year worldwide, which means that HPV is a major problem for public health. Knowing that the most effective and cost-effective way to control an infectious disease is the development of vaccines, two prophylactic vaccines have been developed and approved in Brazil, one of which is bivalent and the other is tetravalent. This review of the literature seeks to present the characteristics of the HPV virus, types of vaccines available on the market, their indications and contraindications, their adverse effects, their effectiveness, their geometric mean titer (GMT) and their cost-effectiveness.</description><identifier>EISSN: 1678-4561</identifier><identifier>DOI: 10.1590/1413-81232014199.01532013</identifier><identifier>PMID: 25184585</identifier><language>por</language><publisher>Brazil</publisher><subject>Contraindications ; Cost-Benefit Analysis ; Female ; Health Policy ; Humans ; Papillomavirus Infections - complications ; Papillomavirus Infections - prevention & control ; Papillomavirus Vaccines - economics ; Papillomavirus Vaccines - immunology ; Uterine Cervical Neoplasms - prevention & control ; Uterine Cervical Neoplasms - virology</subject><ispartof>Ciência & saude coletiva, 2014-09, Vol.19 (9), p.3799</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25184585$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zardo, Geisa Picksius</creatorcontrib><creatorcontrib>Farah, Flávia Peixoto</creatorcontrib><creatorcontrib>Mendes, Fernanda Gabriela</creatorcontrib><creatorcontrib>Franco, Camila Ament Giuliani Dos Santos</creatorcontrib><creatorcontrib>Molina, Giseli Vieira Machado</creatorcontrib><creatorcontrib>Melo, Gislaine Nochetti de</creatorcontrib><creatorcontrib>Kusma, Solena Ziemer</creatorcontrib><title>Vaccines as an agent for immunization against HPV</title><title>Ciência & saude coletiva</title><addtitle>Cien Saude Colet</addtitle><description>Considered a highly prevalent infection throughout the world, the human papillomavirus (HPV) is a DNA virus that infects the genital mucosa and has high carcinogenic potential, being related to an increased risk of lower genital tract lesions, such as cervical cancer. This cancer is responsible for the deaths of about 231,000 women per year worldwide, which means that HPV is a major problem for public health. Knowing that the most effective and cost-effective way to control an infectious disease is the development of vaccines, two prophylactic vaccines have been developed and approved in Brazil, one of which is bivalent and the other is tetravalent. This review of the literature seeks to present the characteristics of the HPV virus, types of vaccines available on the market, their indications and contraindications, their adverse effects, their effectiveness, their geometric mean titer (GMT) and their cost-effectiveness.</description><subject>Contraindications</subject><subject>Cost-Benefit Analysis</subject><subject>Female</subject><subject>Health Policy</subject><subject>Humans</subject><subject>Papillomavirus Infections - complications</subject><subject>Papillomavirus Infections - prevention & control</subject><subject>Papillomavirus Vaccines - economics</subject><subject>Papillomavirus Vaccines - immunology</subject><subject>Uterine Cervical Neoplasms - prevention & control</subject><subject>Uterine Cervical Neoplasms - virology</subject><issn>1678-4561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1jt1Kw0AUhBdBbK2-gqwPsPWc_cvmUopaoaAX2tty9ieyYtKQTS_06U2xwsB8DMwwjN0iLNHUcIcalXAolYQJ63oJaI6sztgcbeWENhZn7LKUTwBZKS0v2EwadNo4M2e4pRBylwqnSR2nj9SNvNkPPLftocs_NOb9MabclZGvX7dX7Lyhr5KuT75g748Pb6u12Lw8Pa_uN6JHcKOQBsBZqryXDUZDFiFo56RVFCjEGFGDMjoli4qgsjUZ73XUfioBNVot2M3fbn_wbYq7fsgtDd-7_-_qF65DRMU</recordid><startdate>201409</startdate><enddate>201409</enddate><creator>Zardo, Geisa Picksius</creator><creator>Farah, Flávia Peixoto</creator><creator>Mendes, Fernanda Gabriela</creator><creator>Franco, Camila Ament Giuliani Dos Santos</creator><creator>Molina, Giseli Vieira Machado</creator><creator>Melo, Gislaine Nochetti de</creator><creator>Kusma, Solena Ziemer</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>201409</creationdate><title>Vaccines as an agent for immunization against HPV</title><author>Zardo, Geisa Picksius ; Farah, Flávia Peixoto ; Mendes, Fernanda Gabriela ; Franco, Camila Ament Giuliani Dos Santos ; Molina, Giseli Vieira Machado ; Melo, Gislaine Nochetti de ; Kusma, Solena Ziemer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-250086a7bb2f1d5a610c488263acacddd140354ee613a0769a5bb4d4b86a0af43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>por</language><creationdate>2014</creationdate><topic>Contraindications</topic><topic>Cost-Benefit Analysis</topic><topic>Female</topic><topic>Health Policy</topic><topic>Humans</topic><topic>Papillomavirus Infections - complications</topic><topic>Papillomavirus Infections - prevention & control</topic><topic>Papillomavirus Vaccines - economics</topic><topic>Papillomavirus Vaccines - immunology</topic><topic>Uterine Cervical Neoplasms - prevention & control</topic><topic>Uterine Cervical Neoplasms - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zardo, Geisa Picksius</creatorcontrib><creatorcontrib>Farah, Flávia Peixoto</creatorcontrib><creatorcontrib>Mendes, Fernanda Gabriela</creatorcontrib><creatorcontrib>Franco, Camila Ament Giuliani Dos Santos</creatorcontrib><creatorcontrib>Molina, Giseli Vieira Machado</creatorcontrib><creatorcontrib>Melo, Gislaine Nochetti de</creatorcontrib><creatorcontrib>Kusma, Solena Ziemer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Ciência & saude coletiva</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zardo, Geisa Picksius</au><au>Farah, Flávia Peixoto</au><au>Mendes, Fernanda Gabriela</au><au>Franco, Camila Ament Giuliani Dos Santos</au><au>Molina, Giseli Vieira Machado</au><au>Melo, Gislaine Nochetti de</au><au>Kusma, Solena Ziemer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccines as an agent for immunization against HPV</atitle><jtitle>Ciência & saude coletiva</jtitle><addtitle>Cien Saude Colet</addtitle><date>2014-09</date><risdate>2014</risdate><volume>19</volume><issue>9</issue><spage>3799</spage><pages>3799-</pages><eissn>1678-4561</eissn><abstract>Considered a highly prevalent infection throughout the world, the human papillomavirus (HPV) is a DNA virus that infects the genital mucosa and has high carcinogenic potential, being related to an increased risk of lower genital tract lesions, such as cervical cancer. This cancer is responsible for the deaths of about 231,000 women per year worldwide, which means that HPV is a major problem for public health. Knowing that the most effective and cost-effective way to control an infectious disease is the development of vaccines, two prophylactic vaccines have been developed and approved in Brazil, one of which is bivalent and the other is tetravalent. This review of the literature seeks to present the characteristics of the HPV virus, types of vaccines available on the market, their indications and contraindications, their adverse effects, their effectiveness, their geometric mean titer (GMT) and their cost-effectiveness.</abstract><cop>Brazil</cop><pmid>25184585</pmid><doi>10.1590/1413-81232014199.01532013</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1678-4561 |
| ispartof | Ciência & saude coletiva, 2014-09, Vol.19 (9), p.3799 |
| issn | 1678-4561 |
| language | por |
| recordid | cdi_pubmed_primary_25184585 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Contraindications Cost-Benefit Analysis Female Health Policy Humans Papillomavirus Infections - complications Papillomavirus Infections - prevention & control Papillomavirus Vaccines - economics Papillomavirus Vaccines - immunology Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - virology |
| title | Vaccines as an agent for immunization against HPV |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T06%3A10%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccines%20as%20an%20agent%20for%20immunization%20against%20HPV&rft.jtitle=Ci%C3%AAncia%20&%20saude%20coletiva&rft.au=Zardo,%20Geisa%20Picksius&rft.date=2014-09&rft.volume=19&rft.issue=9&rft.spage=3799&rft.pages=3799-&rft.eissn=1678-4561&rft_id=info:doi/10.1590/1413-81232014199.01532013&rft_dat=%3Cpubmed%3E25184585%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/25184585&rfr_iscdi=true |